Trutina Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-28,208
Closed -$1.82M 66
2015
Q1
$1.82M Sell
28,208
-2,660
-9% -$167K 1.5% 26
2014
Q4
$1.82M Sell
30,868
-5,143
-14% -$290K 1.46% 26
2014
Q3
$1.84M Sell
36,011
-2,299
-6% -$115K 1.38% 29
2014
Q2
$1.86M Sell
38,310
-3,100
-7% -$153K 1.37% 32
2014
Q1
$2.15M Sell
41,410
-1,555
-4% -$82.7K 1.59% 25
2013
Q4
$2.28M Sell
42,965
-1,592
-4% -$81.1K 1.97% 22
2013
Q3
$2.06M Sell
44,557
-2,195
-5% -$96.4K 2.02% 21
2013
Q2
$2.09M Buy
+46,752
New +$2.03M 1.69% 25

Other funds holding BMY

Trutina Financial's BMY Position: Q2 2015 in Review

Trutina Financial sold out of Bristol-Myers Squibb (BMY) in Q2 2015, closing a stake of 28,208 shares — an estimated $1.82M sold.

Trutina Financial first reported a position in BMY in Q2 2013 and held it in 8 quarters. The position peaked at $2.28M in Q4 2013. 1,447 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

  • Trutina Financial reported no remaining Bristol-Myers Squibb position as of Q2 2015 after selling out during the quarter.
  • Trutina Financial sold 28,208 Bristol-Myers Squibb shares in Q2 2015, an estimated $1.82M.
  • Trutina Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 8 quarters.
  • Trutina Financial's Bristol-Myers Squibb position peaked at $2.28M in Q4 2013.
  • 1,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Trutina Financial's 13F filing for Q2 2015, filed 11 Aug 2015.